Skip to main content
. 2022 Nov 17;79(12):596. doi: 10.1007/s00018-022-04565-y

Fig. 1.

Fig. 1

CPI-455 reduced CP-induced HC loss in ex vivo cochlear explants. AC Cochlear explants were stained for Myosin 7a (red) and DAPI (blue). Scale bar  10 μm. DF Graphical representation of the number of Myosin 7a–positive HCs per each treatment. The data are presented as the mean ± SEM values. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 compared with the control; ##P < 0.01, ###P < 0.001, ####P < 0.0001 compared with CP only. The experiments were performed in triplicate. n = 6 cochleae for control group; n = 6 cochleae for CP group; n = 6 cochleae for 50 μmol/L CPI-455 + CP group; n = 6 cochleae for 100 μmol/L CPI-455 + CP group; n = 6 cochleae for 200 μmol/L CPI-455 + CP group; n = 6 cochleae for 100 μmol/L CPI-455 group